Using Real-World Data to Explore and Demonstrate Comparative Effectiveness

Sponsored by:

Date:

July 19, 2022

Time (ET):

11:00 AM

Duration (min):

Dr. Jessica Paulus explores opportunities and challenges with using RWD in conducting comparative effectiveness research.

Real-world data (RWD) can provide valuable insights into treatment effectiveness and be used to generate evidence for decision making. Understanding which data, when and how to use it, and special considerations when leveraging for regulatory and other stakeholders are all critical to success for RWD comparative effectiveness research (CER). Dr. Jessica Paulus explores opportunities and challenges with using RWD in conducting CER, including; methods to reduce bias, regulatory considerations, and examples of large real-world datasets and use case applications.

Presenters

Jessica Paulus

OM1 Inc. (Research)

Vice President

Jess Paulus, ScD is the Senior Director of Epidemiology at OM1. She received her doctorate in Epidemiology from Harvard T.H. Chan School of Public Health and holds an adjunct appointment at Tufts University School of Medicine. She leads a team of epidemiologists at OM1 to leverage real world data to inform clinical and regulatory decision making.

OM1

With specialization in chronic diseases, OM1 is a leading real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes.

Content Partners

HealthEconomics.com

HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.

HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.

Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.

Topics

Real-World Data (RWD)

Real-World Evidence (RWE)

Using Real-World Data to Explore and Demonstrate Comparative Effectiveness

Presenters

Jessica Paulus

Sponsor

OM1

Content Partners

HealthEconomics.com

Topics

Watch Now

Related Content

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

From Clinical Data to Actionable Assets for Pharmaceutical R&D

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Delphi Panels: What Are They Good For?

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

The role of patient-centric technologies & tokenization in RWE studies

How to assess the quality of AI output when structuring unstructured medical data

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

Synthesise RWE and AI. Transform patient-driven healthcare

Notice of Pre-Application Webinar for RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"

Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology

Connecting Real-World Data and Domain Expertise to Enhance Trial Design and Planning

Pairing quality genomic data with longitudinal patient records

Keeping pace with the evolving global landscape in vaccine development

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

How to Supercharge Real World Evidence Generation in Phase IV Trials

HEOR Writing: The Ins and Outs of Value Communications

The Future of Real-World Evidence: Pharma's Next Moves, Upcoming Webinar Hosted by Xtalks

Digital therapeutics: Software is now entering mainstream therapeutic care

Longitudinal Patient Data - Addressing Common Questions & Unlocking the Value of Real-World Data, Upcoming Webinar Hosted by Xtalks

Workshop: Harnessing the Power of EHR Data and AI to Advance Biomedical Research

Addressing Common Research Questions with Real World Data Best Practices

Optimize Your Decentralized Clinical Trials with Real-World Data

Real World Evidence for COVID-19: Making an impact now and into the future

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Medicare Part D: Price Negotiation Panel Discussion

Finding Value in Linking Real-World Data with Social Determinants of Health

Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help

Designing Causal Inference Studies Using Real-World Data

Social Media Data: Opportunities and Insights for Clinical Research

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

Achieving Consensus When Everyone is an Expert, but No One Agrees

An Introduction to Infectious Disease Modeling

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient